Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis

Liver X receptor (LXR) signaling pathways regulate lipid metabolism and inflammation, which has generated widespread interest in developing synthetic LXR agonists as potential therapeutics for the management of atherosclerosis. In this study, we demonstrate that nanoparticles (NPs) containing the sy...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Adv Healthc Mater
Glavni autori: Zhang, Xue-Qing, Even-Or, Orli, Xu, Xiaoyang, van Rosmalen, Mariska, Lim, Lucas, Gadde, Suresh, Farokhzad, Omid C., Fisher, Edward A.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527680/
https://ncbi.nlm.nih.gov/pubmed/25156796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201400337
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items